Aims Neointimal formation after percutaneous coronary intervention (PCI), termed restenosis, limits therapeutic revascularization. Since it is now known that vascular injury involves an inflammatory response, we examined the role of tumour necrosis factor-a (TNF-a) and interferon-g (IFN-g) in the neointimal formation after injury. Methods and results Control (BALB/c), TNF-a-deficient (Tnf 2/2 ), IFN-g-deficient (Ifng 2/2 ), or doubledeficient (Tnf 2/2 Ifng 2/2 ) mice were subjected to wire-mediated vascular injury of the right femoral artery. Neointimal formation after injury was significantly reduced after the injury in the Tnf 2/2 Ifng 2/2 mice, compared to that in the control, Tnf 2/2 , and Ifng 2/2 mice. Immunohistochemical analysis showed that TNF-a and IFN-g were expressed in neointimal lesions in the control mice, but not in mice with deficiency of the corresponding cytokine. No significant difference in re-endothelialization was observed among these groups. The number of proliferating cell nuclear antigen in the neointimal lesions was significantly decreased in the Tnf 2/2 Ifng 2/2 mice. Bone marrow transplantation experiments revealed that deficiency of TNF-a and IFN-g specifically in bone marrow cells significantly inhibited neointimal formation after vascular injury. Conclusion The absence of TNF-a and IFN-g in bone marrow cells synergistically inhibits neointimal formation following vascular injury, and thus, may provide new insights into the mechanisms underlying restenosis after PCI.
Introduction
Neointimal formation after vascular injury is the pathological basis of atherosclerosis and restenosis following a percutaneous coronary intervention (PCI), such as angioplasty and stenting. Although the pathogenic mechanisms have not been completely elucidated, an accumulating body of evidence suggests that inflammatory response plays a key role in these processes. Tumour necrosis factor-a (TNF-a) and interferon-g (IFN-g) are inflammatory cytokines that mediate a wide range of immune and inflammatory responses and have been found to be involved in the development of post-PCI restenosis and atherosclerosis. It has been reported that TNF-a stimulates the expression of adhesion molecules and the proliferation and migration of vascular smooth muscle cells (VSMCs), and that is up-regulated at the site of vascular injury and in atherosclerotic plaque specimens.
1,2 On the other hand, IFN-g has also been shown to be expressed in vascular lesions and to regulate the expression of platelet-derived growth factor receptor-b that promotes the proliferation of VSMCs. 3, 4 However, the in vivo role of these cytokines remains controversial. For instance, inhibition of TNF-a by gene disruption resulted in reduced neointimal formation in a murine model of carotid artery injury. 5 In contrast, the inhibition of TNF-a by neutralizing antibody had no effect on neointimal formation following vascular injury in rabbits. 6 With regard to the role of IFN-g, the administration of recombinant IFN-g inhibited VSMC proliferation and neointimal formation after vascular injury. 7, 8 On the other hand, the inhibition of IFN-g pathway due to the overexpression of a soluble mutant of IFN-g receptor inhibited only neointimal formation after injury. 9 In addition, several studies have demonstrated that TNF-a and IFN-g synergistically regulate many biological functions, including gene induction and cellular proliferation. 10 In the present study, we investigated the effect of TNF-a and/or IFN-g deficiency on neointimal formation following vascular injury in mice. Recent evidence indicates a critical role of bone marrow cell-derived cytokines in the pathogenesis of restenosis and atherosclerosis; 11 however, no information is available on the role of bone marrow cellderived TNF-a and IFN-g in vascular injury. Therefore, we prepared the irradiation/bone marrow transplantation (BMT) model and determined the role of bone marrow cellderived TNF-a and IFN-g. The findings of our study suggest the synergistic role of TNF-a and IFN-g derived from bone marrow cells in neointimal formation after injury and provide new insights into the mechanism underlying restenosis and atherosclerosis.
Materials and methods

Animals
The animal experimental protocol used in this study was reviewed and approved by the Shinshu University Guide for Laboratory Animals. The investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institute of Health (NIH Publication No. 85-23, revised 1996). The animals were fed a standard diet and water, and were maintained on a 12 h light and dark cycle. BALB/c mice (male, 8-12 weeks old) were purchased from Japan SLC Inc. (Hamamatsu, Japan) and used as control throughout this study. Tnf 2/2 and Ifng 2/2 mice were generated as described previously. 12 Both these mutant animals were backcrossed to the BALB/c background at least 12 times. Mice with either of these two mutations were crossed to generate double-knockout mice (Tfn 2/2 Infg 2/2 ).
Wire-mediated vascular injury
A wire-mediated vascular injury of the right femoral artery was produced as described previously. 13 We confirmed that this procedure induced a reproducible neointimal formation in 8-12 weeks old mice.
14,15
Histology and immunohistochemistry
Histological and immunohistochemical analyses were performed as described previously. 11 Mice were euthanized after brief irrigation with saline to ensure that the blood was completely washed out of the femoral artery. The femoral arteries were excised from each mouse, embedded in the optimal cutting temperature (OCT) compound (Tissue-Tek; Miles Laboratories, IN, USA), and frozen in liquid nitrogen. Neointimal formation in the femoral arteries was evaluated at five locations at 100 mm intervals, with the most distal site located at the origin of branch through which a wire was inserted. The sections were stained with elastica van Gieson (EVG). To measure the intimal and medial areas, each image was digitized and analysed under a microscope (BX-51; Olympus, Tokyo, Japan) by using NIH image software ver. 1.63 . The values at the five locations in each artery were averaged. All the measurements were performed in a double-blind manner by two different researchers.
For immunohistochemical analysis, arterial sections were incubated with primary antibodies against TNF-a (ab6671; Abcam, Cambridge, MA, USA), IFN-g (BioSource International Inc., Camarillo, CA, USA), CD31 (clone MEC13.3; BD Biosciences, San Jose, CA, USA), F4/80 (clone A3-1; RDI, Flanders, NJ, USA), a-smooth muscle actin (a-SMA, clone 1A4, alkaline phosphatase (AP)-conjugated; Sigma, Saint Louis, MO, USA), and proliferating cell nuclear antigen (PCNA, Dako Cytomation, Glostrup, Denmark). This was followed by incubation with biotin-conjugated secondary antibodies. Next, the sections were washed and treated with avidinperoxidase (ABC kit; Vector Laboratories, Burlingame, CA, USA). The reaction was developed using the DAB Substrate Kit (Vector Laboratories). Vector Red AP substrate kit was used for a-SMA staining. The sections were then counterstained with haematoxylin. No signals were detected when species-and isotype-matched immunoglobulin (Ig)G (Vector Laboratories) was used instead of the primary antibody as a negative control. Quantitative staining for CD31, F4/80, and a-SMA was quantified independently performed in a double-blind manner by at least two researchers.
Bone marrow transplantation
Bone marrow-transplanted mice were developed as described previously. 11, 14 Whole bone marrow cells from the control and Tfn 2/2 Infg 2/2 mice were harvested by flushing their femurs with phosphate-buffered saline (PBS). Red blood cells were lysed with ammonium chloride potassium buffer (150 mM NH 4 Cl, 10 mM KHCO 3 , 0.1 mM ethylenediaminetetraacetic acid; pH 7.2) at 48C for 20 min. They were washed three times with PBS and resuspended in 0. 5 (BMT Cont!Tnf-/-Ifng-/-) mice.
Statistical analysis
Data are expressed as mean + SEM. The unpaired two-tailed t-test was used to compare the two groups. For comparisons between multiple groups, we determined the significance of the differences between the means of the groups by using one-way analysis of variance, followed by the Tukey-Kramer procedure for comparison of means. All analyses were performed using StatView software (Abacus Concepts Inc., Berkeley, CA, USA). Differences with P-values of ,0.05 were considered to be statistically significant.
Results
Expression of tumour necrosis factor-a and interferon-g in neointimal lesions
We next examined whether TNF-a and IFN-g were expressed in the neiointimal lesion after injury. The expression of TNF-a and IFN-g was clearly visualized in the neointimal lesion at 28 days after injury by using immunohistochemical analysis ( Figure 1) . As expected, TNF-a was not expressed in 
Effects of tumour necrosis factor-a and/or interferon-g deficiency on neointimal formation following injury
We first investigated whether TNF-a and/or IFN-g deficiency influenced the development of neointimal formation after wire-mediated vascular injury. EVG staining showed marked neointimal formation in the control mice at 28 days after vascular injury (Figure 2A) . Although neointimal formation did not significantly differ between the control mice and Tnf mice and the other three types of mice ( Figure 2B-D) .
Detection of endothelial cells, macrophages, and vascular smooth muscle cells
Since we previously demonstrated that early re-endothelialization following vascular injury inhibits neointimal formation, 14 immunohistochemical analysis of the endothelial marker CD31 was performed. No significant difference was observed in the re-endothelialization after injury among these mice ( Figure 3A and B) . Further, we performed immunohistochemical analysis to detect macrophages (F4/ 80) and VSMCs (a-SMA), and assessed the cellular contents of neointima in the mice. Consistent with previous reports, 13, 16 our finding was that the neointimal lesion was composed of many VSMCs and some macrophages ( Figure 3A) . The number of macrophages and VSMCs per unit neointimal area did not differ among the mice ( Figure 3C and D) .
Proliferation activity in neointimal lesions
Neointimal lesions after vascular injury mainly comprise proliferative VSMCs; we determined their proliferation activity in vivo by immunohistochemical staining for PCNA. The number of PCNA-positive cells significantly decreased in the neointimal lesions in Tnf 2/2 Ifng 2/2 mice compared to that in the control mice (Figure 4) . 
Role of bone marrow cell-derived tumour necrosis factor-a and interferon-g in neointimal formation
To assess the role of bone marrow cell-derived TNF-a and IFN-g in neointimal formation after vascular injury, we produced three types of bone marrow-transplanted mice (BMT following vascular injury in BMT Cont!Cont mice tended to be reduced when compared with that in the wild-type mice (no irradiation) ( Figure 5A and B) . Moreover, neointimal formation in BMT Tnf-/-Ifng-/-!Cont was significantly decreased when compared with that in BMT Cont!Cont (I/M ratio, P , 0.01) and BMT Cont!Tnf-/-Ifng-/-(P , 0.05). These results indicate that TNF-a and IFN-g in bone marrow cells are critical for neointimal formation following vascular injury.
Discussion
The major findings of this study are as follows: (i) neointimal formation following vascular injury was significantly reduced in the Tnf 2/2 Ifng 2/2 mice compared to that in the control, Increasing evidence indicates the importance of inflammatory responses in the pathogenesis of restenosis and atherosclerosis. Although TNF-a and IFN-g are inflammatory cytokines and have been shown to be involved in this pathogenetic process, the precise role of these cytokines is controversial. Furthermore, the synergistic induction of atherogenic genes by TNF-a and IFN-g has been demonstrated; 10 Indeed, TNF-a and IFN-g have been shown to synergistically induce many atherogenic genes, such as those encoding adhesion molecules [intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1)], inflammatory cytokines/chemokines [interleukin (IL)-6, IL-8, regulated on activation, normal T expressed and secreted (RANTES), monokine-induced by IFN-g (Mig), and IFN-g-inducible protein (IP-10)], nicotinamide adenine dinucleotide phosphate oxidases (NADPH oxidases), and inducible nitric oxide synthase (iNOS). 10 The molecular mechanism of the synergistic effect appears to involve the interaction of transcription factors, such as TNF-a-activated nuclear factor-kB (NF-kB), with IFN-g-activated signal transducer and activator of transcription 1 (Stat-1) or interferon regulatory factor-1 (IRF-1). Our finding that double deficiency of TNF-a and IFN-g synergistically inhibited neointimal formation after injury may also support these observations; however, further investigations are required to elucidate its precise mechanism.
We clearly demonstrated that bone marrow cell-derived TNF-a and IFN-g are critical for neointimal formation after vascular injury. Previously, several investigators showed that the expression of TNF-a and IFN-g is upregulated in the injured arteries at the early phase of vascular injury. 5, 6, 9 Furthermore, recent investigations have also demonstrated the contribution of bone marrow cells to neointimal formation after injury; 11, 16 however, the precise role of bone marrow cells has not yet been fully understood. Our data suggest the critical role of bone marrow cells as a cellular source of TNF-a and IFN-g. On the basis of our findings, we postulated the mechanism responsible for neointimal formation after injury as follows: (i) vascular injury directs bone marrow-derived cells such as monocytes and lymphocytes to the injury site in the artery; (ii) the accumulated bone marrow-derived cells secrete inflammatory cytokines such as TNF-a and IFN-g; and (iii) secreted TNF-a and IFN-g cytokines initiate the migration and proliferation of VSMCs, thereby resulting in neointimal formation. Thus, bone marrow-derived TNF-a and IFN-g could be therapeutic targets for the prevention of restenosis and atherosclerosis.
Several limitations of this study should be noted. First, gene disruption in mice might compensate for the loss of signalling pathways by altering the expression of other proteins although no information about such compensation in Tnf 2/2 and Ifng 2/2 mice is available. Second, the model used in this study is not a reliable experimental model of human PCI because the injury was produced on a normal nonatheromatous artery. Third, irradiation has been reported to cause many deleterious effects on recipient animals, such as inhibiting cellular proliferation and inducing apoptotic cells death. 17 In fact, Tanaka et al. 18 recently demonstrated that the neointimal formation following vascular injury in irradiated bone marrow-transplanted mice was less than that in non-irradiated mice and suggested that bone marrow-transplanted mice may not always represent a physiological process that occurs naturally in response to injury in non-irradiated mice. Consistent with their findings, we also observed reduced neointimal formation after injury in BMT Cont!Cont mice, suggesting that other models (e.g. parabiosis model 18 ) might be useful for exploring the precise role of bone marrow-derived cells.
In conclusion, we showed that double deficiency of TNF-a and IFN-g synergistically inhibited neointimal formation after vascular injury. Particularly, the absence of these cytokines in bone marrow cells plays a critical role in the inhibition of the progression of neointimal formation. Our results indicate the importance of the synergistic effect of TNF-a and IFN-g in bone marrow cells and that these cytokines are novel therapeutic targets for restenosis and atherosclerosis.
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